A histamine H2 receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade
Hiroyuki Takahama(Tohoku University), Masafumi Kitakaze(Hanwa Memorial Hospital), Masanori Asakura(National Cerebral and Cardiovascular Center), Jiyoong Kim(National Cerebral and Cardiovascular Center), Masashi Fujita(Kindai University), Kazuo Komamura, Masakatsu Wakeno(Kindai University), Shoji Sanada(Kobe University Hospital), Seiji Takashima(The University of Osaka), H. Sasaki(Tohoku University), Masaru Sugimachi(National Cerebral and Cardiovascular Center), Tetsuo Minamino(Kagawa University), Hiroshi Asanuma(Meiji University of Integrative Medicine)
Cited by 42
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
|Journal of Clinical Investigation|2007|1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288